If in fact all of the predictions of the CEO come to fruition with over 5 billion in sales with a ten percent net that would be 500 million giving a $5 per share earnings. It would not be unreasonable to see a 16 pe of resulting in a price of 80.
obviously the sales story will take several years to play out. I think the key to the price appreciation will be how much visibility the company has in getting there. Many people in the past, including analysts, have expressed concern that NPS will not be able to manage a global growth strategy on their own. I completely disagree. In fact, one of the reasons I have invested in both NPS and Keryx is because their drugs have a narrow specialist population of docs to call on, and the patients are concentrated at specialized treatment centers. I honestly don't think we will see $80 or $100 a share. I think big pharma will acquire NPS before then, but if they decide to go it alone, I'm all in.